Clinical Trial Update: Study of OGX-011 Given Prior to Radical Prostatectomy in Patients With Localized Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating OGX-011 (custirsen) given before radical prostatectomy in localized prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• OGX-011 (custirsen)

Snippet

Sponsor: University of British Columbia | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED